<?xml version="1.0" encoding="UTF-8"?>
<p>Lycorine has been reported to possess 
 <italic>in vitro</italic> anticancer activities against ovarian carcinoma cell line (SK-OV-3) with an IC
 <sub>50</sub> value of 0.86 
 <italic>μ</italic>g/ml [
 <xref rid="B31" ref-type="bibr">31</xref>]. Lycorine has also displayed inhibitory properties towards various cancer cell lines including lymphoma, multiple myeloma, melanoma, leukemia, lung cancer, esophageal cancer, and human anaplastic oligodendroglioma [
 <xref rid="B31" ref-type="bibr">31</xref>].
</p>
